Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $0.4616 per ML under NDC 71288020303. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jan 27, 2022. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Meitheal Pharmaceuticals Inc.NDC
71288020303
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212803FDA Approved
1/27/2022
TE Code
AP
On Market Since
1/27/2022
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4616 per ML |
|---|---|
| All-time high | $0.6277 (May 15, 2024) |
| All-time low | $0.3473 (Dec 17, 2025) |
| 52-week high | $0.4616 |
| 52-week low | $0.3473 |
| Median price | $0.4073 |
| Average price | $0.4359 |
| Largest weekly change | -22.5% (Dec 18, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Meitheal Pharmaceuticals Inc., is $0.4616 per ML (NDC 71288020303), effective Aug 19, 2026.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has declined 26.5%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Apr 17, 2024, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Dec 17, 2025) to a high of $0.6277 (May 15, 2024), with a median of $0.4073 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2658 per ML — about 42% below FUROSEMIDE 20 MG/2 ML VIAL.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 71288020303) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.